礼来美股盘前涨近1.5%

Group 1 - The core point of the article is that Eli Lilly's stock rose nearly 1.5% in pre-market trading following the announcement that Walmart will provide prescription services for the Zepbound injection [1] Group 2 - Eli Lilly's stock performance indicates positive market sentiment towards the company's recent developments [1] - The partnership with Walmart for Zepbound injection services may enhance accessibility and distribution of the product [1]